Seeing what cancer patients eat during radiation treatment using a mobile food diary

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-group feasibility study enrolling 20 adults starting a new course of cancer radiation therapy. Participants will use the myCircadian Clock app to record their daily dietary intake during treatment, with in-person or e-consent. No follow-up data are collected after the treatment period. The study aims to determine if this mobile approach is practical and acceptable for documenting diet in this patient group.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients age ≥18 starting a new course of radiation therapy for cancer treatment
* Written informed consent obtained from participant and ability for participant to comply with the requirements of the study.
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Own a smartphone or smart device
* Able to read and speak English

Exclusion Criteria:

* Pregnant or lactating women per self report prior to starting radiation therapy

Where it's running

• University Of Minnesota
  Minneapolis, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Dr. Lindsey Sloan — University of Minnesota
• Study coordinator: Dr. Lisa Chow, MD, MS
• Email: Chow0007@umn.edu
• Phone: 612-625-8934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• FAPI-guided radiotherapy with cadonilimab plus chemo for colorectal cancer limited to the peritoneum

  Aims to see if adding targeted radiotherapy and cadonilimab immunotherapy to standard second-line chemotherapy helps adults with colorectal cancer that’s spread only to the peritoneum.

  Recruiting Phase 3 Fudan University · Shanghai, Shanghai Municipality · NCT07815834

• Pelvic ultra-hypofractionated radiotherapy after surgery for high-risk endometrial cancer

  This trial tests whether giving 27.5 Gy in five sessions of pelvic radiotherapy after surgery is safe and feasible for high-risk endometrial cancer patients.

  Recruiting Instituto de Investigación Sanitaria Aragón · Zaragoza, Zaragoza · NCT07779109

• Radiation-related heart damage in locally advanced NSCLC tested with PET-CT

  This study tests whether PET-CT imaging with 18F-Flurpiridaz can detect early radiation-related heart damage in adults with locally advanced non-small cell lung cancer receiving standard chemoradiation.

  Recruiting Phase 2 Indiana University · Indianapolis, Indiana · NCT07761910

• Mobile health approach to support first-year Ethiopian female students’ sexual health, nutrition, and wellbeing

  A mobile health program will test whether monthly app-based education can improve sexual and reproductive health, nutrition, and psychosocial wellbeing among first-year female university students in Ethiopia.

  Recruiting Bahir Dar University · Bahir Dar, Amhara · NCT07746791

• CAIX PET/CT–guided radiation for clear cell kidney cancer

  This trial will try using CAIX-targeted PET/CT scans plus FDG PET/CT to guide focused stereotactic radiation alongside standard targeted therapy and anti‑PD‑1 immunotherapy for adults with recurrent or metastatic clear cell kidney cancer.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07540260

• Radiation therapy options compared for newly diagnosed gynecologic cancers

  This study tests whether proton therapy works as well as conventional photon therapy for endometrial and cervical cancers.

  Recruiting at 5 sites Phase 2 University of Maryland, Baltimore · Baltimore, Maryland and 4 other locations · NCT07415681

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.